 |
|
Researcher Profile - Lewis Opler |
|
|
|
| First Name: | Lewis | | Last Name: | Opler | | Title: | Dr. | | Advanced Degrees: | MD, PhD | | Affiliation: | Columbia | | Department: | Psychiatry | | Street Address 1: | 1051 Revierside Drive | | City: | New York | | State/Province: | NY | | Zip/Postal Code: | 10032 | Country/Territory: | U.S.A. | | Phone: | 9146291605 | | Fax: | 9146684814 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports the following financial or other potential conflicts of interest: [Last Modified: 14 June 2012]
As co-author of the PANSS, I receive royalties for sales of the PANSS Manual |
|
|
View all comments by Lewis Opler
|
Schizophrenia, posttraumatic stress disorder
|
Pharmacology, GABAergic transmission, use of the PANSS, Phenomenology/diagnosis, Glutamatergic transmission
|
Research institute, University, Private practice
|
Co-author of PANSS
Director of the Research Division of the NYS OMH from 1999-2010 |
Kay SR, Fiszbein A, Opler LA. Schizophrenia Bulletin, 1987 |
Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry . 2010 Oct 1 ; 68(7):678-80. |
Treatment of cognition in schizophrenia |
dysfunction in the NMDA-glutamate system |
Ability to visualize through imaging |
Schizophrenia is heterogeneous: an umbrella for a number of different disorders |
|
|
|
|
|
